Now I have all the information I need. Let me write the final review.

## Summary
This paper introduces HG-DCM (History-Guided Deep Compartmental Model), a framework for early-stage pandemic forecasting that transfers knowledge from historical pandemics (Ebola, SARS, Dengue, Influenza) to a novel outbreak (COVID-19). A deep learning backbone maps early-stage time series and metadata to DELPHI compartmental model parameters, learning cross-pandemic priors that regularize forecasting during the cold-start window (2–8 weeks). The paper constructs a multi-pandemic dataset and evaluates on 258 global COVID-19 locations.

## Strengths
- **Novel cross-disease transfer paradigm**: The paper identifies a genuine gap — all prior COVID-19 forecasting methods train only on current-pandemic data. HG-DCM operationalizes knowledge from biologically distinct historical pandemics through a shared mapping function f(T,M)→θ (Eqs. 1–2), with a clear justification that macroscopic spread dynamics are universally constrained by human behavior (lines 25–26). This is the first framework to systematically integrate multiple prior pandemics for forecasting a new one.
- **Well-designed 4-way ablation study**: Table 2 compares HG-DCM against DELPHI (standalone compartmental model), CNN (standalone deep learning), and T-DCM (deep compartmental model without historical data or metadata). This cleanly isolates the contribution of each component: DELPHI overshoots, CNN lacks epidemiological structure, T-DCM underperforms HG-DCM on median MAE at 2 and 4 weeks (Table 2, lines 159–168).
- **Concrete overshooting analysis with formal definition**: The paper formally defines overshooting as predicted cumulative cases exceeding observed by >5× in the final forecasting week (line 170), quantifies it across settings (Figure 4a), and shows a concrete US 8-week example where DELPHI diverges while HG-DCM tracks true cases (Figure 4b). This addresses a specific, interpretable failure mechanism rather than treating error as an opaque number.
- **Interpretable parameter analysis with statistical rigor**: Section 3.2.3 extracts DELPHI parameters predicted by HG-DCM and compares distributions against standalone DELPHI using Wilcoxon signed-rank tests (p < 0.05, lines 200–202). HG-DCM produces tighter, more realistic distributions (e.g., lower infection rates, death rates), suggesting it avoids overfitting to early noise (Figure 5).
- **Strong cold-start performance**: At 2 weeks of training data, HG-DCM reduces median MAE by 38.2% over DELPHI and achieves 2,231 vs CNN's 2,963 (Table 2, lines 165–168). The improvement is largest precisely when data scarcity is most acute, directly supporting the paper's core claim.
- **Thoughtful augmentation design**: Window-shift augmentation uses a retrospectively computed LDoA that is never used during inference (line 94–95), and block-masking simulates realistic missing-data scenarios (line 96). Both strategies show careful awareness of temporal information constraints.

## Weaknesses

### Fatal
None

### Major
- **Mean MAE at 4 weeks reveals catastrophic instability, contradicting the "stability" claim**: Table 2 shows HG-DCM's mean MAE at 4 weeks is 110,452 — roughly 10× worse than CNN (11,238) and 6× worse than T-DCM (17,691). Yet median MAE at the same setting is 1,771 (best of all models). This 62× mean/median ratio indicates HG-DCM produces catastrophically wrong forecasts on a subset of locations. For a paper whose headline claim is "reduces overfitting and improves stability" (abstract, line 9), this extreme heavy-tailed error distribution is a direct contradiction that the paper never acknowledges, discusses, or explains. The paper selectively highlights median MAE when it favors HG-DCM and mean MAE when that favors HG-DCM (e.g., at 6 and 8 weeks), but never confronts the 4-week mean MAE anomaly.

- **Selective metric reporting undermines narrative of consistent dominance**: The paper claims "CNN generally underperforms HG-DCM across all training horizons" (line 188) and "HG-DCM consistently outperforms DELPHI" (line 170). Examining Table 2: at 6 weeks median MAE, CNN (1,188) actually beats HG-DCM (1,276); at 8 weeks median MAE, DELPHI (538) beats HG-DCM (796). On mean MAE, CNN beats HG-DCM at both 2 and 4 weeks. The "consistent dominance" narrative is not supported by the data as reported — the paper cherry-picks the metric (mean vs. median) that looks favorable for each comparison.

- **External comparison against competing methods limited to 2 locations**: Table 1 (comparison vs. GradABM and EiNNs) is restricted to US and Massachusetts due to code/data availability constraints (acknowledged at line 138). However, the abstract claims the approach "outperforms state-of-the-art methods" and the introduction claims results "across 258 global locations" (line 33). These statements are misleading because the 258-location evaluation only applies to the internal ablation (Table 2), not the comparison with competing methods. HG-DCM also does not consistently win even on these 2 locations: it loses to EiNNs at US 4-weeks (2,548,004 vs 729,091) and at Massachusetts 6-weeks (39,887 vs 25,669).

### Minor
- **No variance, confidence intervals, or error distributions reported**: Tables 1 and 2 report only point estimates (mean and median MAE). Given the heavy-tailed error distribution revealed by comparing mean vs. median, the absence of standard deviation, IQR, or per-location error distributions makes it impossible to assess whether reported differences are meaningful. Figure 3 provides density plots only for DELPHI vs. HG-DCM, not for CNN or T-DCM.
- **Loss function hyperparameters α and β not specified in main text**: Eqns 3–5 define α (weighting MAPE vs. MAE) and β (weighting past vs. current pandemic loss) symbolically but never state their values. Since β directly controls how much the model relies on historical vs. current data — the central design choice — omitting its value from the main text hinders reproducibility and interpretability.
- **No ablation on individual historical diseases**: The paper's central mechanism is cross-disease transfer, but there is no analysis of which historical diseases contribute most to performance. Dengue is a vector-borne disease with fundamentally different transmission dynamics from respiratory diseases; an ablation removing individual diseases would directly test the paper's premise about "universal macroscopic patterns."

### Trivial
- The non-standard removal of Batch Normalization (line 75) is well-motivated but would benefit from a simple ablation with/without BN to validate the design choice.

## Nice-to-Haves
- Analysis of which locations produce the catastrophic 4-week errors — what characterizes them? This is the highest-leverage improvement.
- Sensitivity analysis on β would directly demonstrate the value of the historical-vs-current data tradeoff.
- Extending density plots (Figure 3) to all ablation variants would give a complete picture of error distributions.

## Removed Points
These points are flagged to be removed, treat them with caution.
- **Sigmoid ranging of DELPHI parameters (Section 2.1)**: The harsh critic raised concerns about sigmoid constraint limiting expressiveness. The paper states a "sigmoid ranging function" is applied to normalize output values to physical bounds (line 77) — this is standard practice for bounded parameter prediction. Not a real issue.
- **Missing appendix content**: Per rules, concerns about missing appendix content (hyperparameter values, baseline setups) are removed since appendices are stripped from the parsed paper. The appendix likely addresses several of the minor concerns above.
- **BN ablation as "missing"**: The BN removal is justified in the text (line 75) and is a reasonable architectural decision for cross-pandemic training. This is a nice-to-have, not a missing validation.

## Novel Insights
The mean-vs-median MAE discrepancy at 4 weeks is the single most important observation that the paper itself never makes. A 62× gap between mean (110,452) and median (1,771) MAE for HG-DCM at 4 weeks of training data reveals that the model fails catastrophically on a subset of locations while performing excellently on the majority. This is the most critical finding for the authors to address, as it directly challenges the paper's core "stability" narrative and suggests HG-DCM may be trading one form of instability (DELPHI's overshooting) for another (location-dependent catastrophic failure).

## Suggestions
1. Investigate and characterize the locations causing the extreme 4-week mean MAE — what demographic, epidemiological, or data-quality features distinguish them? This is the highest-leverage improvement.
2. Report standard deviations or IQR alongside mean/median MAE in Tables 1–2, and extend density plots to all ablation variants.
3. Add a disease ablation: train HG-DCM without each historical disease in turn to identify which transfers are most valuable.
4. Report α and β values in the main text and add a sensitivity analysis on β.
5. Correct the narrative to accurately reflect where HG-DCM wins and where it doesn't, rather than claiming "consistent" dominance.

## Score and Decision

**Calibration anchors (all rounds):**

| Path | Avg Score | Round | Comparison |
|------|-----------|-------|------------|
| CpiOUOaqh3 | 2.00 | 1 | Basic GA-based SEIR variant. Paper is clearly stronger. |
| V83xzYnZ5q | 3.00 | 1 | Tuberculosis forecasting with incremental method. Paper is stronger. |
| w2C7gJqaai | 2.33 | 1 | Equilibrium state for COVID — less rigorous. Paper is stronger. |
| llW4qRsF0o | 3.00 | 1 | Generic physics-transfer framework. Paper is stronger. |
| vfHISoWo2m | 4.00 | 1 | Meta-learning nonlinear dynamics — less impactful. Paper is stronger. |
| QMkYEau02q | 4.25 | 2 | Physics-guided weather forecasting. Rejected for similar reasons. Paper is slightly stronger. |
| xoZ29eXUk7 | 4.50 | 2 | Multi-agent RL for HIV. Similar rigor level. |
| nTlzEM1x3B | 4.50 | 2 | Zero-shot forecasting framework. Similar level. |
| vXSCD3ToCS | 4.60 | 2 | Traffic transfer learning dataset. Rejected, dataset contribution. Similar. |
| DL7JWbdGr3 | 4.75 | 1, 2 | PEMs — most topically similar (cross-disease epidemic pre-training). Rejected for insufficient baselines. Paper has better ablation and interpretability, but comparable evaluation issues. Paper is slightly stronger. |
| qq0zZMC4SM | 5.00 | 2 | Synthetic datasets for spatio-temporal graphs. Mixed quality. Roughly comparable. |
| Gc2qkiYUkh | 5.20 | 2 | Transfer learning theory. More theoretical, rejected. Similar level. |
| i1BTP8wFYM | 5.25 | 1 | PDEDER — transfer across dynamical systems. Similar ambition with execution gaps. Similar level. |
| Q9OGPWt0Rp | 5.25 | 3 | PINNs for parametric PDEs. Rejected with mixed reviews. Similar. |
| RdFpj6z4nE | 5.67 | 3 | Neural symbolic regression of network dynamics. Borderline reject. Paper is slightly weaker. |
| jqVj8vCQsT | 5.60 | 3 | Neural solver for parametric PDE — accepted with very split scores (3,6,8,8,3). Similar ambition with evaluation concerns. Most comparable anchor; paper is slightly weaker due to selective metric reporting. |
| kbm6tsICar | 6.50 | 3 | "No Equations Needed" — accepted. Cleaner conceptual contribution and evaluation. Paper is weaker. |
| PdaPky8MUn | 8.00 | 1 | "Never Train from Scratch" — strong accept. Paper is clearly weaker. |
| GRMfXcAAFh | 8.00 | 1 | Oscillatory SSMs. Paper is clearly weaker. |
| bH6T0Jjw5y | 8.00 | 1 | Latent representation of Markov processes. Paper is clearly weaker. |
| cmfyMV45XO | 8.00 | 1 | Feedback Neural ODEs. Paper is clearly weaker. |

**Round-1 bracket**: 4.5–6.5 (between weak rejects at 4.5 and moderate accepts at 6.5).
**Round-2 narrowing**: 5.0–6.0. The paper sits above PEMs (4.75) due to better ablation design and interpretability, but slightly below jqVj8vCQsT (5.6, accepted with split reviews) due to the systematic selective metric reporting issue. The paper is notably below kbm6tsICar (6.5) which had a cleaner evaluation.

The paper earns a 5.5: it has genuine novelty (first cross-disease transfer for compartmental models), clean ablation design, and interpretable analysis, but the unaddressed mean/median MAE discrepancy and selective metric reporting are significant enough evaluation concerns to prevent a clear accept.

MY FINAL SCORE: <score>5.5</score>
MY FINAL DECISION: <decision>Reject</decision>